Summary: There is no validated or MHRA-approved protocol for diluting retatrutide outside of an approved clinical trial, as it remains an unlicensed investigational medicine in the UK
Monitoring and Adjustment: Regularly monitor the subjects response to TB-500 nasal spray for any concerns, and make any adjustments needed
Keep a journal to identify if there are, in fact, any triggers that you can work on with your therapist
doi: 10.1080/09546634.2020.1826392 Summary Keywords glucagon-like peptide-1, liraglutide, inflammatory diseases, immunomodulation, signal pathways Citation Chen J, Mei A, Wei Y, Li C, Qian H, Min X, Yang H, Dong L, Rao X and Zhong J (2022) GLP-1 receptor agonist as a modulator of innate immunity
Some patients report mild arm soreness at the injection site or temporary fatigue after the vaccine, which are normal immune responses unrelated to semaglutide use
The same site twice in a row is a quick way to develop irritation or lipohypertrophy